276 related articles for article (PubMed ID: 2234710)
21. Phase I/II study of paclitaxel, cisplatin, and cyclophosphamide in advanced ovarian carcinoma: preliminary results.
Coeffic D; Benhammouda A; Antoine EC; Rixe O; Paraiso D; Auclerc G; Nizri D; Renody N; Grapin JP; Mularoni E; Rattini E; Soubrane C; Weil M; Mortier N; Khayat D
Semin Oncol; 1996 Dec; 23(6 Suppl 15):5-8. PubMed ID: 8996589
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Pecorelli S; Vergote I; Curran D; Wagener DJ; Kobierska A; Bolis G; Bokkel-Huinink WT; Lacave AJ; Madronal C; Forn M; de Oliveira CF; Mangioni C; Nooij MA; Goupil A; Kerbrat P; Marth CH; Tumolo S; Herben MG; Zanaboni F; Vermorken JB
Eur J Gynaecol Oncol; 2001; 22(3):187-93. PubMed ID: 11501769
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival in advanced ovarian cancer after cytoreduction and chemotherapy treatment.
Del Campo JM; Felip E; Rubio D; Vidal R; Bermejo B; Colomer R; Zanon V
Gynecol Oncol; 1994 Apr; 53(1):27-32. PubMed ID: 8175018
[TBL] [Abstract][Full Text] [Related]
24. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Chambers JT; Chambers SK; Kohorn EI; Carcangiu ML; Schwartz PE
Gynecol Oncol; 1996 Mar; 60(3):438-42. PubMed ID: 8774654
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
26. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
27. A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
Resnik E; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1995 Mar; 56(3):370-5. PubMed ID: 7705670
[TBL] [Abstract][Full Text] [Related]
28. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE
Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
[TBL] [Abstract][Full Text] [Related]
30. Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.
Shapiro JD; Rothenberg ML; Sarosy GA; Steinberg SM; Adamo DO; Reed E; Ozols RF; Kohn EC
Cancer; 1998 Nov; 83(9):1980-8. PubMed ID: 9806657
[TBL] [Abstract][Full Text] [Related]
31. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy.
Pectasides D; Barbounis V; Sintila A; Varthalitis I; Dimitriadis M; Athanassiou A
Am J Clin Oncol; 1994 Feb; 17(1):68-71. PubMed ID: 8311012
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of primary cancer of the fallopian tube].
Pakisch B; Poschauko J; Stücklschweiger G; Poier E; Lahousen M; Pickel H; Kohek P; Klug P; Hackl A
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):593-6. PubMed ID: 2210307
[TBL] [Abstract][Full Text] [Related]
33. [Primary fallopian tube cancer].
Böhme M; Donat H; Baumann D
Zentralbl Gynakol; 1992; 114(5):244-8. PubMed ID: 1320802
[TBL] [Abstract][Full Text] [Related]
34. [Primary fallopian tube cancer--an Austrian multicenter study].
Rosen A; Klein M; Lahousen M; Graf AH; Bartussek A; Vavra N; Medl M; Virrani N; Schröck A; Fuith F
Geburtshilfe Frauenheilkd; 1993 May; 53(5):321-5. PubMed ID: 8514103
[TBL] [Abstract][Full Text] [Related]
35. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
36. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Sevelda P
Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
[TBL] [Abstract][Full Text] [Related]
37. Primary carcinoma of the fallopian tube: evidence for activity of cisplatin combination therapy.
Maxson WZ; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Gynecol Oncol; 1987 Mar; 26(3):305-13. PubMed ID: 3557196
[TBL] [Abstract][Full Text] [Related]
38. Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate.
Fung MF; Krepart GV; Lotocki RJ; Heywood M
Obstet Gynecol; 1991 Dec; 78(6):1033-8. PubMed ID: 1945203
[TBL] [Abstract][Full Text] [Related]
39. [The study of cyclic maintenance chemotherapy with cisplatin, adriamycin, and cyclophosphamide (cyclic PAC chemotherapy) in patients with advanced ovarian cancer].
Kobayashi H; Hayata T; Terao T; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1936-42. PubMed ID: 2592816
[TBL] [Abstract][Full Text] [Related]
40. Results of chemotherapy in advanced carcinoma of the fallopian tube.
Peters WA; Andersen WA; Hopkins MP
Cancer; 1989 Mar; 63(5):836-8. PubMed ID: 2914291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]